The Ratings Game: Better Therapeutics stock surges on ‘big milestone’ after FDA approves smartphone-based diabetes treatment

Better Therapeutics shares surged in the extended session Monday after the company got FDA approval for its smartphone-based behavioral diabetes therapy.

Previous post Earnings Outlook: Megabank profits on tap after eventful Q2 of bank failures and climbing interest rates
Next post FA Center: Why this is not a good time to put more money into stocks